entertainment -WSS

entertainment

author：fashion 2025-10-01 23:57:20 - browse：67894

LONDON — AstraZeneca said on Monday that a new lung cancer treatment outperformed standard-of-care chemotherapy in a trial, but investors found the results less impressive than anticipated, sending company shares down in early trading.

Based on an interim analysis of a Phase 3 trial, the company said that the drug, datopotamab deruxtecan, led to improvement in progression-free survival in patients non-small cell lung cancer, a primary endpoint of the study. There was also a positive early trend on overall survival, with Susan Galbraith, AstraZeneca’s oncology leader, describing the results as “compelling evidence for the potential role” that the drug could play for patients.

But investors had been hoping for a clearer signal of benefit. Analysts noted that despite the success in progression-free survival, it was not described as a “clinically meaningful” improvement, which, as J.P. Morgan analysts wrote, “we believe the market would have liked to have seen.”

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： IVF, abortion rights issues kick off Biden’s State of the Union

focus

WSS

Readout Newsletter: Acadia, Eli Lilly, Madrigal Pharma updates

What causes osteoarthritis? Researchers study link to brain protein

Head of FDA's diagnostics center, who led through Covid, retires

The drug industry has found itself all alone in Washington

Medicare bonuses could stop drug shortages under Senate plan

FDA sets aggressive timeline for overhauling inspection procedures

hotspot

entertainment

Wikipedia

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Amylyx ALS drug fails large clinical trial

Bright Health sells Medicare Advantage business to Molina

Change Healthcare cyberattack prompts Medicare loan program

23andMe had bad news about my health. I wish a person had delivered it

HPV vaccine, cervical cancer study delivers historic results

What does generative AI mean for health care? We asked experts

RSV shot was 90% effective at preventing hospitalizations in kids

Medical records are filled with copy

UnitedHealth quietly bought dozens of outpatient centers

hotspot

What causes osteoarthritis? Researchers study link to brain protein

The drug industry has found itself all alone in Washington

Amylyx ALS drug fails large clinical trial

What it’s like to watch children die of measles

To bolster infectious disease surveillance, genomics powerhouses team up

Dana Farber says 6 studies to be retracted and 31 corrected

focus

focus

hotspot

Wikipedia